Circulating HOTAIR RNA Is Potentially Up-regulated in Coronary Artery Disease

Coronary artery disease (CAD) is one of the leading causes of death and disability all around the world. Recent studies have revealed that aberrantly regulated long non-coding RNA (lncRNA) as one of the main classes of cellular transcript play a key regulatory role in transcriptional and epigenetic...

Full description

Saved in:
Bibliographic Details
Published inGenomics & informatics Vol. 16; no. 4; pp. e25 - 25
Main Authors Avazpour, Niloofar, Hajjari, Mohammadreza, Yazdankhah, Saeed, Sahni, Azita, Foroughmand, Ali Mohammad
Format Journal Article
LanguageEnglish
Published Korea (South) 한국유전체학회 01.12.2018
Subjects
Online AccessGet full text
ISSN1598-866X
2234-0742
DOI10.5808/GI.2018.16.4.e25

Cover

Loading…
More Information
Summary:Coronary artery disease (CAD) is one of the leading causes of death and disability all around the world. Recent studies have revealed that aberrantly regulated long non-coding RNA (lncRNA) as one of the main classes of cellular transcript play a key regulatory role in transcriptional and epigenetic pathways. Recent reports have demonstrated circulating long noncoding RNAs in blood can be potential biomarkers for CAD. HOTAIR is one of the most cited lncRNAs with a critical role in initiation and progression of the gene expression regulation. Recent research on the role of the HOTAIR in cardiovascular disease lays the basis for the development of new studies considering this lncRNA as a potential biomarker and therapeutic target in CAD. In this study, we aimed to compare the expression of HOTAIR lncRNA in the blood samples of patients with CAD and control samples. The expression level was examined by semi-quantitative reverse transcriptase polymerase chain reaction technique. Our data show that expression of HOTAIR is up-regulated in blood samples of patients with CAD.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1598-866X
2234-0742
DOI:10.5808/GI.2018.16.4.e25